P&G director granted 250 restricted stock units

Procter & Gamble director Christopher J. Kempczinski received 250 RSUs, bringing his direct holdings to about 11,934 PG shares.

Rhea-AI Filing Summary

PROCTER & GAMBLE Co (symbol: PG) is the issuer of record for a Form 4 filing submitted to the SEC. Kempczinski Christopher J reported acquisition or exercise transactions in this Form 4 filing.

PROCTER & GAMBLE Co (PG) reported that director Christopher J. Kempczinski received an award of 250 Restricted Stock Units (RSUs) of common stock on September 8, 2026. The RSUs were granted at $0.00 per share under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and include dividend equivalents in the form of additional RSUs. Following this grant, Kempczinski directly holds 11,933.6723 shares of Procter & Gamble common stock.

Insider Trade Summary

Grant/Award: 250 shares

Grant/Award 1 txn

Insider Kempczinski Christopher J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	250	$0.00	$0.00

Holdings After Transaction: Common Stock — 11,933.6723 shares (Direct)

Footnotes (2)

1. F1. Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
2. F2. Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Key Figures

RSUs granted: 250 shares Reported price per RSU: $0.00 per share Holdings after transaction: 11,933.6723 shares

3 metrics

RSUs granted 250 shares Restricted Stock Units awarded to director Kempczinski on September 8, 2026

Reported price per RSU $0.00 per share Compensation-related RSU award, not a market purchase

Holdings after transaction 11,933.6723 shares Direct holdings of Procter & Gamble common stock after RSU grant

Key Terms

Restricted Stock Units, dividend equivalents, Stock and Incentive Compensation Plan

3 terms

Restricted Stock Units financial

"Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend equivalents financial

"Total includes grant of dividend equivalents in the form of Restricted"

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

Stock and Incentive Compensation Plan financial

"awarded pursuant to The Procter & Gamble 2025 Stock and Incentive"

FAQ

What insider transaction did PG disclose for Christopher J. Kempczinski?

PG disclosed that director Christopher J. Kempczinski received 250 Restricted Stock Units of common stock on September 8, 2026, as a grant or award under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

How many PG shares does Christopher J. Kempczinski hold after this Form 4 transaction?

After the reported RSU grant, Christopher J. Kempczinski directly holds 11,933.6723 shares of Procter & Gamble common stock, including amounts attributable to dividend equivalents granted in the form of additional RSUs.

Was the September 8, 2026 PG Form 4 transaction a purchase or a grant?

The September 8, 2026 Form 4 for PG reports a grant/award acquisition of 250 Restricted Stock Units to director Christopher J. Kempczinski, not an open-market purchase or sale.

What price per share is reported for Christopher J. Kempczinski’s PG RSU award?

The Form 4 reports the 250 Restricted Stock Units for Christopher J. Kempczinski at a price of $0.00 per share, consistent with a compensation-related equity award rather than a cash purchase.

Was Kempczinski’s PG RSU award made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not affirmed, and the footnotes describe the transaction as Restricted Stock Units awarded under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 02:33 PM Accepted by SEC EDGAR 09/10/2026 - 02:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kempczinski Christopher J

(Last) (First) (Middle)

1 PROCTER & GAMBLE PLAZA

(Street)

CINCINNATI OHIO 45202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2026		A		250	A	$0(1)	11,933.6723(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

2. Total includes grant of dividend equivalents in the form of Restricted Stock Units.

	/s/ Wednesday Shipp, attorney-in-fact for Christopher Kempczinski	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)